Ethereum's Decline Triggers Massive Sell-Off in 180 Life Sciences Stock

180 Life Sciences Corp. (ATNF) shares slid 1.45% in after-hours trading, coinciding with the decline of Ethereum (ETH). ETH's decline triggered a 28% decline in ATNF's stock during the regular trading session. ATNF has been on a tear lately, surging as much as 116% in a week and 755% in a month, aligning with ETH's rise in this period. The company holds 82,186 ETH, valued at over $381 million, and plans to rebrand as ETHZilla Corporation.

180 Life Sciences Corp. (ATNF) shares experienced a significant decline of 28% during the regular trading session on July 2, 2025, coinciding with a 3.38% increase in Ethereum's (ETH) price to $4,431 over a 24-hour period. The stock's after-hours trading saw a 1.45% drop, reflecting the broader market's reaction to Ethereum's price drop. The biotechnology company's stock has surged 116% in a week and 755% in a month, aligning with ETH's rise during this period.

The company holds 82,186 ETH, valued at approximately $349 million, and plans to rebrand as ETHZilla Corporation. The recent surge in ATNF's stock can be attributed to the company's Ethereum treasury strategy, which involves accumulating ETH to become a benchmark for on-chain treasury management among public companies. The strategy aims to generate cash flow for shareholders through a differentiated yield generation program facilitated by a partnership with Electric Capital.

Despite the recent gains, the stock's after-hours decline reflects the broader market's reaction to Ethereum's price drop. The company's stock has seen a year-to-date increase of 83.52% and a 91.95% rise over the past 12 months. The recent announcement has led to heavy trading, with approximately 33 million shares changing hands on July 2, 2025, compared to a three-month average of about 4.78 million units.

Billionaire venture capitalist Peter Thiel holds a 7.5% stake in the firm, adding further credibility to the company's strategy. The company's treasury strategy is part of its broader evolution from a biotechnology company to a software-enabled gaming and entertainment enterprise.

References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
[2] https://www.ainvest.com/news/180-life-sciences-stock-plunges-ethereum-decline-2508/